Anna Altomari

Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease

Alessandro Mantovani, G Lunardi, Stefano Bonapace et al. · Diabetes & Metabolism · 2020 · 47 citations · Full text

Metabolic Syndrome, Heart Failure, Renal Disease +9

From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients

Maria Grazia Zenti, Anna Altomari, Maria Giovanna Lupo et al. · European Journal of Preventive Cardiology · 2018 · 22 citations · Full text

Impact of bariatric surgery-induced weight loss on circulating PCSK9 levels in obese patients

Maria Grazia Zenti, Maria Giovanna Lupo, Sara De Martin et al. · Nutrition Metabolism and Cardiovascular Diseases · 2020 · 16 citations · Full text

Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes

Alessandro Mantovani, Anna Altomari, G Lunardi et al. · Diabetes & Metabolism · 2019 · 15 citations

Metabolic Syndrome, Specific Plasma Ceramides, Cardiovascular Disease +14